130 related articles for article (PubMed ID: 36175647)
1. Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation.
Kjaer J; Smith S; Hellman P; Stålberg P; Crona J; Welin S; Norlén O
World J Surg; 2023 Feb; 47(2):340-347. PubMed ID: 36175647
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
Rossi RE; Burroughs AK; Caplin ME
Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.
Gedaly R; Daily MF; Davenport D; McHugh PP; Koch A; Angulo P; Hundley JC
Arch Surg; 2011 Aug; 146(8):953-8. PubMed ID: 21844436
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation in patients with liver metastases from neuroendocrine tumors.
Spolverato G; Bagante F; Tsilimigras DI; Pawlik TM
Minerva Chir; 2019 Oct; 74(5):399-406. PubMed ID: 31280548
[TBL] [Abstract][Full Text] [Related]
5. Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.
Yang M; Ke NW; Zhang Y; Zeng L; Tan CL; Zhang H; Mai G; Tian BL; Liu XB
Medicine (Baltimore); 2015 Dec; 94(48):e2156. PubMed ID: 26632896
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
[TBL] [Abstract][Full Text] [Related]
7. What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?
Stiefel R; Lehmann K; Winder T; Siebenhüner AR
BMC Cancer; 2023 Feb; 23(1):148. PubMed ID: 36782152
[TBL] [Abstract][Full Text] [Related]
8. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
[TBL] [Abstract][Full Text] [Related]
9. Indication for liver transplantation in young patients with small intestinal NETs is rare?
Norlén O; Daskalakis K; Öberg K; Åkerström G; Stålberg P; Hellman P
World J Surg; 2014 Mar; 38(3):742-7. PubMed ID: 24233660
[TBL] [Abstract][Full Text] [Related]
10. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines.
Foulfoin M; Graillot E; Adham M; Rousset P; Forestier J; Hervieu V; Robinson P; Scoazec JY; Lombard-Bohas C; Walter T
Endocr Relat Cancer; 2017 Feb; 24(2):71-81. PubMed ID: 27965277
[TBL] [Abstract][Full Text] [Related]
12. Where Are We Now with Liver Transplantation in Neuroendocrine Neoplasms? The Place of Liver Transplantation for Grades 1 and 2 Well-Differentiated Unresectable Liver Metastatic Neuroendocrine Tumours.
Shah T; Manas DM; Ford SJ; Dasari BVM; Gibbs P; Venkataraman H; Moore J; Hughes S; Elshafie M; Karkhanis S; Smith S; Hoti E; O'Toole D; Caplin ME; Isaac J; Mazzafero V; Thorburn D
Curr Oncol Rep; 2023 Feb; 25(2):135-144. PubMed ID: 36648705
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
Moris D; Tsilimigras DI; Ntanasis-Stathopoulos I; Beal EW; Felekouras E; Vernadakis S; Fung JJ; Pawlik TM
Surgery; 2017 Sep; 162(3):525-536. PubMed ID: 28624178
[TBL] [Abstract][Full Text] [Related]
14. Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors.
Du S; Ni J; Weng L; Ma F; Li S; Wang W; Sang X; Lu X; Zhong S; Mao Y
Medicine (Baltimore); 2015 Aug; 94(34):e1429. PubMed ID: 26313798
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis.
Máthé Z; Tagkalos E; Paul A; Molmenti EP; Kóbori L; Fouzas I; Beckebaum S; Sotiropoulos GC
Transplantation; 2011 Mar; 91(5):575-82. PubMed ID: 21200365
[TBL] [Abstract][Full Text] [Related]
16. Younger Age Is Associated with Improved Survival in Patients Undergoing Liver Transplantation Alone for Metastatic Neuroendocrine Tumors.
Valvi D; Mei X; Gupta M; Shah MB; Ancheta A; Marti F; Gedaly R
J Gastrointest Surg; 2021 Jun; 25(6):1487-1493. PubMed ID: 32632728
[TBL] [Abstract][Full Text] [Related]
17. Con: Liver transplantation for expanded criteria malignant diseases.
Schaefer B; Zoller H; Schneeberger S
Liver Transpl; 2018 Jan; 24(1):104-111. PubMed ID: 29125687
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review.
Bonaccorsi-Riani E; Apestegui C; Jouret-Mourin A; Sempoux C; Goffette P; Ciccarelli O; Borbath I; Hubert C; Gigot JF; Hassoun Z; Lerut J
Transpl Int; 2010 Jul; 23(7):668-78. PubMed ID: 20478000
[TBL] [Abstract][Full Text] [Related]
19. The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors.
Mazzaferro V; Sposito C; Coppa J; Miceli R; Bhoori S; Bongini M; Camerini T; Milione M; Regalia E; Spreafico C; Gangeri L; Buzzoni R; de Braud FG; De Feo T; Mariani L
Am J Transplant; 2016 Oct; 16(10):2892-2902. PubMed ID: 27134017
[TBL] [Abstract][Full Text] [Related]
20. The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: Pros and cons.
Sposito C; Droz Dit Busset M; Citterio D; Bongini M; Mazzaferro V
Rev Endocr Metab Disord; 2017 Dec; 18(4):473-483. PubMed ID: 29359266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
